# Boston Scientific Corporation (BSX) — Q3-2020 Earnings Results

**Report date:** 2020-10-28 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2020

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 5.49%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | +45.10% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management acknowledged the impact of COVID-19 on operations but remained focused on long-term growth. They did not provide updated guidance for future performance.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They noted ongoing challenges due to the pandemic but expressed confidence in recovery.

> No specific guidance was provided for future quarters.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a significant beat on EPS, indicating better-than-expected profitability. However, the stock fell by 5.49%, likely due to the lack of revenue details and forward guidance. Investors may be concerned about ongoing challenges from the pandemic affecting future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2020_